Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $44000.0.

  • Prime Medicine's Other Non Operating Income rose 15301.2% to $44000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $142000.0, marking a year-over-year decrease of 273.97%. This contributed to the annual value of $41000.0 for FY2024, which is 8503.65% down from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Other Non Operating Income is $44000.0, which was up 15301.2% from $18000.0 recorded in Q2 2025.
  • Prime Medicine's 5-year Other Non Operating Income high stood at $2.1 million for Q1 2023, and its period low was -$83000.0 during Q3 2024.
  • For the 5-year period, Prime Medicine's Other Non Operating Income averaged around $260058.8, with its median value being $42000.0 (2024).
  • In the last 5 years, Prime Medicine's Other Non Operating Income surged by 7290000.0% in 2022 and then crashed by 29302.33% in 2024.
  • Prime Medicine's Other Non Operating Income (Quarter) stood at $12000.0 in 2021, then skyrocketed by 7616.67% to $926000.0 in 2022, then crashed by 84.02% to $148000.0 in 2023, then tumbled by 70.95% to $43000.0 in 2024, then increased by 2.33% to $44000.0 in 2025.
  • Its last three reported values are $44000.0 in Q3 2025, $18000.0 for Q2 2025, and $37000.0 during Q1 2025.